Home LiteratureArticle Details
PMID: 3861481 Published · ppublish English Journal Article

Plasminogen activator as a prognostic factor in hematological malignancies.

Haematology and blood transfusion ·Vol. 29 ·1985-00-00 ·Pages 197-9

Wilson EL, Jacobs P, Oliver L

Abstract

暂无摘要

MeSH Terms
Antineoplastic Combined Chemotherapy Protocols/therapeutic use Cells, Cultured Clinical Laboratory Techniques Humans Leukemia, Myeloid/metabolism,pathology Leukemia, Myeloid, Acute/drug therapy,metabolism,pathology Plasminogen Activators/metabolism Prognosis Urokinase-Type Plasminogen Activator/metabolism
Chemicals
Plasminogen Activators Urokinase-Type Plasminogen Activator
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Wilson E L
Jacobs P
Oliver L
Article Info
Journal
Haematology and blood transfusion
Abbr.
Haematol Blood Transfus
ISSN
0171-7111
DOI
10.1007/978-3-642-70385-0_45
Published
1985-00-00
Pages
197-9
Language
English
Region
Germany
NLM ID
101169459
Subset
IM
External Links
PubMed source DOI: 10.1007/978-3-642-70385-0_45
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2